EIP
Epoch Investment Partners Portfolio holdings
AUM
$19.3B
This Quarter Return
+6.22%
1 Year Return
+19.15%
3 Year Return
+76.35%
5 Year Return
+147.93%
10 Year Return
+300.25%
AUM
$17.3B
AUM Growth
+$17.3B
(+2.8%)
Cap. Flow
-$395M
Cap. Flow
% of AUM
-2.29%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
469
New
33
Increased
150
Reduced
226
Closed
29
Top Buys
| 1 |
AstraZeneca
AZN
|
$73.1M |
| 2 |
ON Semiconductor
ON
|
$70.1M |
| 3 |
Regions Financial
RF
|
$56.8M |
| 4 |
International Flavors & Fragrances
IFF
|
$55.9M |
| 5 |
VICI Properties
VICI
|
$52.1M |
Top Sells
| 1 |
Broadcom
AVGO
|
$89.4M |
| 2 |
Microsoft
MSFT
|
$87.3M |
| 3 |
Synopsys
SNPS
|
$67.7M |
| 4 |
KeyCorp
KEY
|
$56.2M |
| 5 |
Humana
HUM
|
$51.9M |
Sector Composition
| 1 | Technology | 21.67% |
| 2 | Healthcare | 15.58% |
| 3 | Financials | 13.46% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.77T
| $528M | 3.06% | 1,551,649 -256,485 | -14% | -$87.3M |
|
2
Apple
AAPL
$3.45T
| $331M | 1.91% | 1,705,214 -125,240 | -7% | -$24.3M |
|
|
3
Broadcom
AVGO
$1.4T
| $320M | 1.85% | 368,993 -103,081 | -22% | -$89.4M |
|
4
Coca-Cola Europacific Partners
CCEP
$40.4B
| $250M | 1.45% | 3,887,737 +787,687 | +25% | +$50.8M |
|
5
UnitedHealth
UNH
$281B
| $242M | 1.4% | 503,592 +1,594 | +0.3% | +$766K |
|
6
Meta Platforms (Facebook)
META
$1.86T
| $238M | 1.38% | 828,925 -178,206 | -18% | -$51.1M |
|
7
Chevron
CVX
$324B
| $236M | 1.37% | 1,499,736 -17,430 | -1% | -$2.74M |
|
8
JPMorgan Chase
JPM
$829B
| $229M | 1.32% | 1,573,192 -58,786 | -4% | -$8.55M |
|
9
Cisco
CSCO
$274B
| $210M | 1.21% | 4,053,904 -102,026 | -2% | -$5.28M |
|
10
Analog Devices
ADI
$124B
| $209M | 1.21% | 1,072,501 -80,166 | -7% | -$15.6M |
|
11
IBM
IBM
$227B
| $194M | 1.12% | 1,451,944 -74,374 | -5% | -$9.95M |
|
|
12
AstraZeneca
AZN
$248B
| $188M | 1.09% | 2,620,822 +1,021,770 | +64% | +$73.1M |
|
13
Bank of America
BAC
$376B
| $184M | 1.07% | 6,427,092 +693,858 | +12% | +$19.9M |
|
14
Linde
LIN
$224B
| $180M | 1.04% | 471,055 -51,794 | -10% | -$19.7M |
|
15
Eli Lilly
LLY
$657B
| $179M | 1.04% | 382,720 -19,157 | -5% | -$8.98M |
|
16
Texas Instruments
TXN
$184B
| $176M | 1.02% | 976,565 -37,577 | -4% | -$6.76M |
|
17
KLA
KLAC
$115B
| $174M | 1.01% | 359,204 -36,030 | -9% | -$17.5M |
|
18
AbbVie
ABBV
$372B
| $172M | 1% | 1,279,116 -61,107 | -5% | -$8.23M |
|
19
Berkshire Hathaway Class B
BRK.B
$1.09T
| $162M | 0.94% | 475,601 -26,821 | -5% | -$9.15M |
|
20
Merck
MRK
$210B
| $159M | 0.92% | 1,380,672 -18,961 | -1% | -$2.19M |
|
21
CVS Health
CVS
$92.8B
| $159M | 0.92% | 2,293,521 +292,069 | +15% | +$20.2M |
|
22
Iron Mountain
IRM
$27.3B
| $155M | 0.9% | 2,725,178 -160,192 | -6% | -$9.1M |
|
23
RTX Corp
RTX
$212B
| $149M | 0.86% | 1,522,072 -91,710 | -6% | -$8.98M |
|
24
MetLife
MET
$54.1B
| $148M | 0.86% | 2,617,682 +48,730 | +2% | +$2.75M |
|
25
Johnson & Johnson
JNJ
$427B
| $147M | 0.85% | 887,497 +10,530 | +1% | +$1.74M |
|